MARKET

IRON

IRON

Disc Medicine Inc
NASDAQ
80.18
-0.41
-0.51%
Opening 10:12 08/13 EDT
OPEN
81.32
PREV CLOSE
80.59
HIGH
81.32
LOW
79.74
VOLUME
41.37K
TURNOVER
--
52 WEEK HIGH
99.50
52 WEEK LOW
40.00
MARKET CAP
3.08B
P/E (TTM)
-12.2064
1D
5D
1M
3M
1Y
5Y
1D
Disc Medicine (IRON) Gets a Buy from Wedbush
TipRanks · 2d ago
Analysts Conflicted on These Healthcare Names: CVRx (CVRX), Jazz Pharmaceuticals (JAZZ) and Disc Medicine (IRON)
TipRanks · 2d ago
H.C. Wainwright Sticks to Its Buy Rating for Disc Medicine (IRON)
TipRanks · 3d ago
Weekly Report: what happened at IRON last week (0803-0807)?
Weekly Report · 3d ago
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Barchart · 6d ago
Analysts Are Bullish on Top Healthcare Stocks: MannKind (MNKD), Disc Medicine (IRON)
TipRanks · 08/06 10:40
Disc Medicine Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 08/06 10:26
Disc Medicine Price Target Raised to $120.00/Share From $118.00 by HC Wainwright & Co.
Dow Jones · 08/06 10:26
More
About IRON
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The Company's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps), including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. It is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.

Webull offers Disc Medicine Inc stock information, including NASDAQ: IRON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IRON stock methods without spending real money on the virtual paper trading platform.